Nick Keen
Novartis (United States)(US)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Protein Tyrosine Phosphatases, Bioactive Compounds and Antitumor Agents, Galectins and Cancer Biology
Most-Cited Works
- → Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor(2016)286 cited
- → Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer(2020)210 cited
- → Biochemical Characterization of Human SET and MYND Domain-Containing Protein 2 Methyltransferase(2011)54 cited
- → A novel Aurora B kinase inhibitor with potent anticancer activity either as a single agent or in combination with chemotherapy(2004)18 cited
- → The Activity of the Novel Aurora Kinase B Inhibitor AZD1152 in Acute Myeloid Leukaemia Cells.(2005)8 cited
- Novel pyrazole- and thiazole-substituted quinazolines as potent aurora kinase inhibitors.(2006)
- On-set photograph from 'Comrades'(2009)